Thus, in a combined model of Mbd2−/− colitis susceptibility (Graphical Abstract), we speculate that at the onset of intestinal inflammation, the Mbd2 deficient epithelium leads to further intestinal damage, through Cxcl9 driven CD8+ T-cell recruitment and EC-MHC-II upregulation. Here, CXCL9 is linked to colitis.